Orca Bio

Orca Bio is a late-stage biotechnology company developing high-precision allogeneic cell therapies for the treatment of cancer and autoimmune diseases. Its approach engineers purified cell populations, including regulatory T cells, to improve patient outcomes while reducing the risks associated with traditional allogeneic transplant. Its flagship product, TREGZI, is described as the first FDA-approved precision-engineered cell therapy for allogeneic transplant in adults with hematological malignancies. Orca Bio is backed by 8vc, DCVC and Lightspeed Venture Partners. The company publishes no public API or developer platform; this profile captures its identity within the API Evangelist network.

Orca Bio is profiled on the APIs.io network. Tagged areas include Company, Biotech, Cell Therapy, Immunotherapy, and Oncology.

Orca Bio’s developer surface includes engineering blog, support, and 1 more developer resources.

🌐 Visit website 📡 Source on GitHub
6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechCell TherapyImmunotherapyOncologyHealthcareLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 6.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/orca-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support
Support

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: orca-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/orca-bio.png
name: Orca Bio
description: Orca Bio is a late-stage biotechnology company developing high-precision allogeneic cell therapies for the treatment
  of cancer and autoimmune diseases. Its approach engineers purified cell populations, including regulatory T cells, to improve
  patient outcomes while reducing the risks associated with traditional allogeneic transplant. Its flagship product, TREGZI,
  is described as the first FDA-approved precision-engineered cell therapy for allogeneic transplant in adults with hematological
  malignancies. Orca Bio is backed by 8vc, DCVC and Lightspeed Venture Partners. The company publishes no public API or developer
  platform; this profile captures its identity within the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/orca-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- 8vc
- dcvc
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotech
- Cell Therapy
- Immunotherapy
- Oncology
- Healthcare
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://orcabio.com
- type: Blog
  url: https://orcabio.com/newsroom/
- type: Support
  url: https://orcabio.com/contact-us/
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1